These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1397014)

  • 21. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.
    Cambridge D; Whiting MV; Butterfield LJ; Marston C
    Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between serotonin and tryptamine receptors in the rat stomach fundus.
    Cohen ML; Wittenauer LA
    J Pharmacol Exp Ther; 1985 Apr; 233(1):75-9. PubMed ID: 3981465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs.
    Clancy BM; Maayani S
    J Pharmacol Exp Ther; 1985 Jun; 233(3):761-9. PubMed ID: 4009488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The behavioural effects of intravenously administered tryptamine in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Neuropharmacology; 1987 Jan; 26(1):49-53. PubMed ID: 3561719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
    Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST; Lewis SJ; Brody MJ; Gebhart GF
    Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists.
    Sternberg EM; Trial J; Parker CW
    J Immunol; 1986 Jul; 137(1):276-82. PubMed ID: 2423604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
    Stollak JS; Furchgott RF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):215-21. PubMed ID: 6129317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of tryptamine on serotonin release from hypothalamic slices is mediated by a cholinergic interneurone.
    Ennis C; Cox B
    Psychopharmacology (Berl); 1982; 78(1):85-8. PubMed ID: 6815702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of spasmogens from rat isolated lungs by tryptamines.
    Bakhle YS; Smith TW
    Eur J Pharmacol; 1977 Nov; 46(1):31-9. PubMed ID: 21802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
    Rittenhouse PA; Bakkum EA; Van de Kar LD
    J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice.
    Larson AA; Wilcox GL
    Neuropharmacology; 1984 Dec; 23(12A):1415-8. PubMed ID: 6335574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.